Marketplace

Leading through a period of trial

The biotechnology company Amgen produces two drugs for anemia that have earned the company billions of dollars. But new findings could result in strong warnings being placed on the drugs. Amgen CEO Kevin Sharer talked about his company's situation with Kai Ryssdal.

Amgen Chairman, President and CEO Kevin Sharer (Amgen photo)

More on Conversations from the Corner Office, Health

Most popular stories online

1. Allegations against U of Phoenix persist
2. What to do with your credit cards
3. Examining U of Phoenix recruitment
4. Talking money back at her old school
5. Need work? Trying making your own.

Also on This Show

• Toy industry tries to get the lead out
• An easy-to-read label is hard to find
• Troop cuts could mean contractor surge
• KKR makes offer to reassure its lenders
• Syria transfers to modern banking
• Watch out for those library fines
• Leading through a period of trial

Music From This Show

• The Man Who Told Everything Doves
• Pellican Narrows Caribou
• Close My Eyes Ride
• Fiction Reprise Belle and Sebastian
• The Dope Dandy Warhols

The Specials

GAME: Budget Hero

Think you could balance the federal budget? Play the game.

Conversations from the Corner Office^TM

Marketplace goes one-on-one with CEOs, company founders, head honchos...

Sit in

Working

Intimate profiles of workers in the global economy.

Meet them

Marketplace on iTunes U

Marketplace is on Apple's online education platform, iTunesU. Get free downloads in subjects like History, Science, Business and more. Study up

Find past stories by . . .

Past Shows